TEAS Request Reconsideration after FOA

ACES

Apogepha Arzneimittel GmbH

TEAS Request Reconsideration after FOA

PTO Form (Rev 4/2000)
OMB No. 0651-.... (Exp. 08/31/2004)

Request for Reconsideration after Final Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 79043104
LAW OFFICE ASSIGNED LAW OFFICE 108
MARK SECTION (no change)
ARGUMENT(S)

REQUEST FOR RECONSIDERATION

 

The applicant hereby respectfully requests the Examining Attorney to reconsider the final refusal to register the applied-for mark.  In the Final Office Action of May 20, 2008 the Examining Attorney upheld her refusal to register applicant’s mark on likelihood of confusion grounds, based on U.S. Registration Nos. 1,604,336, 1, 795,580, 2,230,465, 2,552,273, and 2, 677,092.  The Examining Attorney withdrew all other earlier refusal grounds and objections to the identification of goods. 

In order to overcome the Examining Attorney’s refusal to register, the applicant wishes to amend the identification of goods as described in the following.  The applicant believes that the limiting amendment to the identification of goods proposed in this Request for Reconsideration eliminates any likelihood of confusion with the above-referenced registrations.

Identification of Goods

The applicant wishes to limit the identification of goods to prescription pharmaceuticals and prescription veterinary preparations.  The amended identification of goods shall, therefore, read as follows:

“Pharmaceuticals and veterinary preparations, all for the treatment of urinary tract disorders and diseases and all for sale only by prescription.”

The applicant hereby amends the identification of good as set out in the goods identification field of this Response to Office Action Form. The identification as amended does not include any goods that are not within the scope of the goods set forth in the original identification.

Likelihood of Confusion Refusal

The following will show that the amended limiting identification of goods, as proposed with this Request for Reconsideration, eliminates any likelihood of confusion with the above-referenced U.S. trademark registrations.

First, the applicant wishes to incorporate by reference all arguments against a likelihood of confusion, made in applicant’s Response filed on April 22, 2008.  In addition, the applicant wishes to provide the following arguments:

The applicant’s goods, as amended with this Request for Reconsideration are not similar or related to the goods of the above-referenced U.S. registrations.  The goods associated with four of those registrations are “vitamin preparations” (Reg. No. 1,604,336 “ACES”; Reg. No. 1,795,580 “ACE”; Reg. No. 2,230,465 “ACES GOLD”; Reg. No. 2,552,273 “ACES+ZN”) and the goods associated with one of the registrations are “nutritional supplements” (Reg. No. 2,677,092 “CARDIO ACES”). 

The goods of those five registrations are typically available – without prescription – in  drug stores and health and over-the-counter drug sections of any major grocery store.  In contrast thereto, applicant’s prescription pharmaceuticals and prescription veterinary preparations are only available in pharmacies and on prescription.

Therefore, applicant’s prescription pharmaceuticals and veterinary preparations travel through different channels of trade than the registrant’s vitamin preparations and nutritional supplements.  In addition, due to the nature of applicant’s goods being only available on prescription and registrant’s goods being readily available over the counter, the conditions surrounding the respective marketing of the applicant’s and the registrant’s goods are not such that they would be encountered by the same purchasers under circumstances that would give rise to the mistaken belief that the goods come from a common source.

In light of the amended, limiting identification of goods the Examining Attorney is respectfully requested to withdraw the finality of the Final Office Action and the refusal for likelihood of confusion, and to approve applicant’s mark for publication.

The applicant has attempted to be fully responsive to the Final Office Action.  However, should the Examining Attorney have any further comments or suggestions, the undersigned would very much welcome a telephone call in order to resolve any outstanding issues and expedite placement of the application into condition for publication.

 

GOODS AND/OR SERVICES SECTION (current)
INTERNATIONAL CLASS 005
DESCRIPTION
Pharmaceutical and veterinary preparations for the treatment of urinary tract disorders and diseases; preparations for health care, namely, nutraceuticals for the treatment of urinary tract disorders and diseases
GOODS AND/OR SERVICES SECTION (proposed)
INTERNATIONAL CLASS 005
DESCRIPTION
Pharmaceutical and veterinary preparations for the treatment of urinary tract disorders and diseases and all for sale only by prescription
SIGNATURE SECTION
DECLARATION SIGNATURE The filing Attorney has elected not to submit the signed declaration, believing no supporting declaration is required under the Trademark Rules of Practice.
RESPONSE SIGNATURE /Beate Boudro/
SIGNATORY'S NAME Beate Boudro
SIGNATORY'S POSITION Attorney of record, New Mexico State Bar member
DATE SIGNED 09/09/2008
AUTHORIZED SIGNATORY YES
CONCURRENT APPEAL NOTICE FILED NO
FILING INFORMATION SECTION
SUBMIT DATE Tue Sep 09 15:01:29 EDT 2008
TEAS STAMP USPTO/RFR-XX.XX.XXX.XX-20
080909150129148741-790431
04-430a14a2395b885d48b8df
82fc01623dd-N/A-N/A-20080
909145235454087



PTO Form (Rev 4/2000)
OMB No. 0651-.... (Exp. 08/31/2004)

Request for Reconsideration after Final Action


To the Commissioner for Trademarks:

Application serial no. 79043104 has been amended as follows:

ARGUMENT(S)
In response to the substantive refusal(s), please note the following:

REQUEST FOR RECONSIDERATION

 

The applicant hereby respectfully requests the Examining Attorney to reconsider the final refusal to register the applied-for mark.  In the Final Office Action of May 20, 2008 the Examining Attorney upheld her refusal to register applicant’s mark on likelihood of confusion grounds, based on U.S. Registration Nos. 1,604,336, 1, 795,580, 2,230,465, 2,552,273, and 2, 677,092.  The Examining Attorney withdrew all other earlier refusal grounds and objections to the identification of goods. 

In order to overcome the Examining Attorney’s refusal to register, the applicant wishes to amend the identification of goods as described in the following.  The applicant believes that the limiting amendment to the identification of goods proposed in this Request for Reconsideration eliminates any likelihood of confusion with the above-referenced registrations.

Identification of Goods

The applicant wishes to limit the identification of goods to prescription pharmaceuticals and prescription veterinary preparations.  The amended identification of goods shall, therefore, read as follows:

“Pharmaceuticals and veterinary preparations, all for the treatment of urinary tract disorders and diseases and all for sale only by prescription.”

The applicant hereby amends the identification of good as set out in the goods identification field of this Response to Office Action Form. The identification as amended does not include any goods that are not within the scope of the goods set forth in the original identification.

Likelihood of Confusion Refusal

The following will show that the amended limiting identification of goods, as proposed with this Request for Reconsideration, eliminates any likelihood of confusion with the above-referenced U.S. trademark registrations.

First, the applicant wishes to incorporate by reference all arguments against a likelihood of confusion, made in applicant’s Response filed on April 22, 2008.  In addition, the applicant wishes to provide the following arguments:

The applicant’s goods, as amended with this Request for Reconsideration are not similar or related to the goods of the above-referenced U.S. registrations.  The goods associated with four of those registrations are “vitamin preparations” (Reg. No. 1,604,336 “ACES”; Reg. No. 1,795,580 “ACE”; Reg. No. 2,230,465 “ACES GOLD”; Reg. No. 2,552,273 “ACES+ZN”) and the goods associated with one of the registrations are “nutritional supplements” (Reg. No. 2,677,092 “CARDIO ACES”). 

The goods of those five registrations are typically available – without prescription – in  drug stores and health and over-the-counter drug sections of any major grocery store.  In contrast thereto, applicant’s prescription pharmaceuticals and prescription veterinary preparations are only available in pharmacies and on prescription.

Therefore, applicant’s prescription pharmaceuticals and veterinary preparations travel through different channels of trade than the registrant’s vitamin preparations and nutritional supplements.  In addition, due to the nature of applicant’s goods being only available on prescription and registrant’s goods being readily available over the counter, the conditions surrounding the respective marketing of the applicant’s and the registrant’s goods are not such that they would be encountered by the same purchasers under circumstances that would give rise to the mistaken belief that the goods come from a common source.

In light of the amended, limiting identification of goods the Examining Attorney is respectfully requested to withdraw the finality of the Final Office Action and the refusal for likelihood of confusion, and to approve applicant’s mark for publication.

The applicant has attempted to be fully responsive to the Final Office Action.  However, should the Examining Attorney have any further comments or suggestions, the undersigned would very much welcome a telephone call in order to resolve any outstanding issues and expedite placement of the application into condition for publication.

 



CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 005 for Pharmaceutical and veterinary preparations for the treatment of urinary tract disorders and diseases; preparations for health care, namely, nutraceuticals for the treatment of urinary tract disorders and diseases
Original Filing Basis:
Filing Basis Section 66(a), Request for Extension of Protection to the United States. Section 66(a) of the Trademark Act, 15 U.S.C. §1141f.

Proposed: Class 005 for Pharmaceutical and veterinary preparations for the treatment of urinary tract disorders and diseases and all for sale only by prescription

Filing Basis Section 66(a), Request for Extension of Protection to the United States. Section 66(a) of the Trademark Act, 15 U.S.C. §1141f.

SIGNATURE(S)
Declaration Signature
I hereby elect to bypass the submission of a signed declaration, because I believe a declaration is not required by the rules of practice. I understand that the examining attorney could still, upon later review, require a signed declaration.
Request for Reconsideration Signature
Signature: /Beate Boudro/     Date: 09/09/2008
Signatory's Name: Beate Boudro
Signatory's Position: Attorney of record, New Mexico State Bar member

The signatory has confirmed that he/she is an attorney who is a member in good standing of the bar of the highest court of a U.S. state, which includes the District of Columbia, Puerto Rico, and other federal territories and possessions; and he/she is currently the applicant's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S. attorney or a Canadian attorney/agent not currently associated with his/her company/firm previously represented the applicant in this matter: (1) the applicant has filed or is concurrently filing a signed revocation of or substitute power of attorney with the USPTO; (2) the USPTO has granted the request of the prior representative to withdraw; (3) the applicant has filed a power of attorney appointing him/her in this matter; or (4) the applicant's appointed U.S. attorney or Canadian attorney/agent has filed a power of attorney appointing him/her as an associate attorney in this matter.

The applicant is not filing a Notice of Appeal in conjunction with this Request for Reconsideration.

        
Serial Number: 79043104
Internet Transmission Date: Tue Sep 09 15:01:29 EDT 2008
TEAS Stamp: USPTO/RFR-XX.XX.XXX.XX-20080909150129148
741-79043104-430a14a2395b885d48b8df82fc0
1623dd-N/A-N/A-20080909145235454087



uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed